Patents by Inventor Agnes RAFALKO

Agnes RAFALKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082155
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Application
    Filed: March 30, 2023
    Publication date: March 14, 2024
    Applicant: Glycomine, Inc.
    Inventors: Agnes RAFALKO, Tatyana CHERNENKO
  • Publication number: 20220184107
    Abstract: The disclosure provides phosphorylated carbohydrate replacement therapies (CRT) that include compositions of phosphorylated carbohydrates and phospholipids, as well as methods for preparing such compositions. Such compositions are suitable for pharmaceutical delivery of phosphorylated carbohydrates to cell interior, endoplasmic reticulum, and Golgi, and can be used for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 16, 2022
    Applicant: Glycomine, Inc.
    Inventors: Agnes RAFALKO, Teppei SHIRAKURA, Samuel Eric GREENBERG
  • Publication number: 20220110871
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Application
    Filed: May 21, 2021
    Publication date: April 14, 2022
    Applicant: Glycomine, Inc.
    Inventors: Agnes RAFALKO, Tatyana CHERNENKO
  • Patent number: 11045419
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: June 29, 2021
    Assignee: Glycomine, Inc.
    Inventors: Agnes Rafalko, Tatyana Chernenko
  • Publication number: 20200246266
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Application
    Filed: September 11, 2019
    Publication date: August 6, 2020
    Applicant: Glycomine, Inc.
    Inventors: Agnes RAFALKO, Tatyana CHERNENKO
  • Patent number: 10449149
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: October 22, 2019
    Assignee: Glycomine, Inc.
    Inventors: Agnes Rafalko, Tatyana Chernenko
  • Publication number: 20180036239
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Application
    Filed: October 19, 2017
    Publication date: February 8, 2018
    Applicant: Glycomine, Inc.
    Inventors: Agnes RAFALKO, Tatyana CHERNENKO
  • Publication number: 20160228364
    Abstract: The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders.
    Type: Application
    Filed: September 16, 2014
    Publication date: August 11, 2016
    Applicant: GLYCOMINE, INC.
    Inventors: Agnes RAFALKO, Tatyana CHERNENKO